Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft, Consequences for Morbi/Mortality in the Short and Medium Term

Centre Hospitalier Universitaire Dijon1 site in 1 country286 target enrollmentApril 8, 2015

ConditionsAnomalies in Glucose Metabolism Coronary Artery Bypass Graft

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Anomalies in Glucose Metabolism
Sponsor: Centre Hospitalier Universitaire Dijon
Enrollment: 286
Locations: 1
Primary Endpoint: Percentage of glucose anomalies (non-diabetic fasting hyperglycaemia, glucose intolerance, diabetes) in CAD patients about to undergo coronary artery bypass grafting.
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG).

In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Registry

clinicaltrials.gov

Start Date

April 8, 2015

End Date

June 5, 2019

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Centre Hospitalier Universitaire Dijon

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•persons who have provided oral consent
•patients about to undergo coronary artery bypass grafting
•age \>18 years

Exclusion Criteria

•persons without national health insurance cover
•Adults under guardianship
•Pregnant or breast-feeding women

Outcomes

Primary Outcomes

Percentage of glucose anomalies (non-diabetic fasting hyperglycaemia, glucose intolerance, diabetes) in CAD patients about to undergo coronary artery bypass grafting.

Time Frame: Change from inclusion to week 2 and up to month 3